Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204.SZ)
CNY 8.09
(3.72%)
CNY 8.09
(3.72%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 20.92 Million CNY | 11.15% |
| 2022 | 18.82 Million CNY | -24.71% |
| 2021 | 25 Million CNY | -34.36% |
| 2020 | 38.09 Million CNY | -25.45% |
| 2019 | 51.09 Million CNY | 17.9% |
| 2018 | 43.33 Million CNY | 16.18% |
| 2017 | 37.3 Million CNY | 13.94% |
| 2016 | 32.73 Million CNY | 32.69% |
| 2015 | 24.67 Million CNY | -15.31% |
| 2014 | 29.13 Million CNY | -15.29% |
| 2013 | 34.39 Million CNY | 43.97% |
| 2012 | 23.88 Million CNY | 144.44% |
| 2011 | 9.77 Million CNY | 2.48% |
| 2010 | 9.53 Million CNY | 176.4% |
| 2009 | 3.45 Million CNY | 21.34% |
| 2008 | 2.84 Million CNY | 20.54% |
| 2007 | 2.35 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 20.43 Million CNY | 5.98% |
| 2024 Q2 | 19.27 Million CNY | -10.19% |
| 2024 Q1 | 21.46 Million CNY | 2.57% |
| 2023 Q3 | 28.98 Million CNY | -12.39% |
| 2023 FY | 20.92 Million CNY | 11.15% |
| 2023 Q4 | 20.92 Million CNY | -27.81% |
| 2023 Q2 | 33.08 Million CNY | 11.79% |
| 2023 Q1 | 29.59 Million CNY | 57.18% |
| 2022 Q3 | 27.5 Million CNY | -2.89% |
| 2022 Q1 | 29.78 Million CNY | 19.1% |
| 2022 Q2 | 28.32 Million CNY | -4.89% |
| 2022 FY | 18.82 Million CNY | -24.71% |
| 2022 Q4 | 18.82 Million CNY | -31.55% |
| 2021 Q2 | 26.44 Million CNY | -35.98% |
| 2021 Q4 | 25 Million CNY | -1.93% |
| 2021 FY | 25 Million CNY | -34.36% |
| 2021 Q3 | 25.49 Million CNY | -3.59% |
| 2021 Q1 | 41.31 Million CNY | 8.46% |
| 2020 FY | 38.09 Million CNY | -25.45% |
| 2020 Q1 | 52.92 Million CNY | 3.57% |
| 2020 Q2 | 45.72 Million CNY | -13.61% |
| 2020 Q3 | 47.84 Million CNY | 4.64% |
| 2020 Q4 | 38.09 Million CNY | -20.37% |
| 2019 FY | 51.09 Million CNY | 17.9% |
| 2019 Q4 | 51.09 Million CNY | 18.94% |
| 2019 Q3 | 42.96 Million CNY | 4.23% |
| 2019 Q1 | 40.7 Million CNY | -6.07% |
| 2019 Q2 | 41.21 Million CNY | 1.25% |
| 2018 Q2 | 35.73 Million CNY | 5.8% |
| 2018 Q1 | 33.77 Million CNY | -9.46% |
| 2018 Q4 | 43.33 Million CNY | 17.01% |
| 2018 Q3 | 37.03 Million CNY | 3.65% |
| 2018 FY | 43.33 Million CNY | 16.18% |
| 2017 Q3 | 34.92 Million CNY | 2.86% |
| 2017 Q2 | 33.95 Million CNY | -4.02% |
| 2017 Q1 | 35.37 Million CNY | 8.05% |
| 2017 FY | 37.3 Million CNY | 13.94% |
| 2017 Q4 | 37.3 Million CNY | 6.82% |
| 2016 Q1 | 27.04 Million CNY | 9.61% |
| 2016 Q3 | 25.18 Million CNY | -3.48% |
| 2016 Q2 | 26.09 Million CNY | -3.53% |
| 2016 FY | 32.73 Million CNY | 32.69% |
| 2016 Q4 | 32.73 Million CNY | 30.0% |
| 2015 Q3 | 23.26 Million CNY | -11.81% |
| 2015 FY | 24.67 Million CNY | -15.31% |
| 2015 Q1 | 31.58 Million CNY | 8.4% |
| 2015 Q2 | 26.38 Million CNY | -16.47% |
| 2015 Q4 | 24.67 Million CNY | 6.05% |
| 2014 Q4 | 29.13 Million CNY | 7.11% |
| 2014 Q3 | 27.2 Million CNY | -11.54% |
| 2014 FY | 29.13 Million CNY | -15.29% |
| 2014 Q1 | 35.37 Million CNY | 2.87% |
| 2014 Q2 | 30.74 Million CNY | -13.08% |
| 2013 Q3 | 33.48 Million CNY | 6.19% |
| 2013 FY | 34.39 Million CNY | 43.97% |
| 2013 Q4 | 34.39 Million CNY | 2.72% |
| 2013 Q2 | 31.53 Million CNY | 20.22% |
| 2013 Q1 | 26.22 Million CNY | 9.8% |
| 2012 FY | 23.88 Million CNY | 144.44% |
| 2012 Q1 | 12.67 Million CNY | 29.68% |
| 2012 Q2 | 12.4 Million CNY | -2.1% |
| 2012 Q3 | 17.68 Million CNY | 42.57% |
| 2012 Q4 | 23.88 Million CNY | 35.05% |
| 2011 Q4 | 9.77 Million CNY | -5.02% |
| 2011 FY | 9.77 Million CNY | 2.48% |
| 2011 Q2 | 11.13 Million CNY | 0.16% |
| 2011 Q3 | 10.28 Million CNY | -7.57% |
| 2011 Q1 | 11.11 Million CNY | 16.54% |
| 2010 Q4 | 9.53 Million CNY | 16.27% |
| 2010 FY | 9.53 Million CNY | 176.4% |
| 2010 Q3 | 8.2 Million CNY | 0.0% |
| 2009 FY | 3.45 Million CNY | 21.34% |
| 2008 FY | 2.84 Million CNY | 20.54% |
| 2007 FY | 2.35 Million CNY | 0.0% |